CASTLEGATE AND DERWENT SURGERY — All Prescriptions & Medications — Page 10
Practice Code: A82021 | COCKERMOUTH, CA13 9HT
Showing results 451-500 of 761
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Colestyramine | 46 | 3,844 | £1.9K | +59.7% ▲ |
| Atomoxetine hydrochloride | 46 | 1,666 | £3.4K | +36.0% ▲ |
| Indacaterol/glycopyrronium | 45 | 1,350 | £1.4K | -0.3% vs avg |
| Ergocalciferol | 45 | 1,529 | £205 | +168.8% ▲ |
| Prednisolone acetate | 45 | 270 | £94 | +146.9% ▲ |
| 45 | 4,245 | £7.9K | +33.2% ▲ | |
| Emollient bath and shower preparations | 44 | 20.3K | £245 | -30.0% ▼ |
| 44 | 9,828 | £215 | -11.8% ▼ | |
| Estradiol valerate | 43 | 2,856 | £237 | +120.2% ▲ |
| 43 | 500 | £455 | +38.1% ▲ | |
| Ciprofloxacin | 42 | 972 | £84 | +5.3% ▲ |
| Alogliptin | 42 | 1,125 | £1.0K | -83.4% ▼ |
| Etonogestrel | 42 | 42 | £3.3K | +45.3% ▲ |
| Trospium chloride | 42 | 1,622 | £745 | -17.7% ▼ |
| 42 | 4,170 | £280 | -80.6% ▼ | |
| Cinnarizine | 41 | 4,682 | £212 | -12.4% ▼ |
| Acamprosate calcium | 41 | 5,796 | £665 | +17.7% ▲ |
| Glycerol | 40 | 655 | £104 | +14.0% ▲ |
| Citalopram hydrochloride | 40 | 675 | £462 | +149.2% ▲ |
| Tapentadol | 40 | 3,815 | £2.2K | -2.8% ▼ |
| Liothyronine sodium | 40 | 1,862 | £7.5K | +87.5% ▲ |
| Cabergoline | 39 | 608 | £1.1K | +151.5% ▲ |
| 39 | 622 | £1.4K | +41.0% ▲ | |
| Linaclotide | 38 | 1,064 | £1.4K | +108.0% ▲ |
| Varenicline tartrate | 38 | 1,576 | £2.0K | +283.8% ▲ |
| 38 | 2,280 | £3.7K | +115.5% ▲ | |
| 38 | 2,316 | £844 | +29.3% ▲ | |
| Erythromycin | 37 | 1,916 | £703 | +6.8% ▲ |
| Insulin detemir | 37 | 310 | £2.6K | -52.8% ▼ |
| Betamethasone sodium phosphate | 37 | 2,088 | £277 | +200.9% ▲ |
| Magnesium glycerophosphate | 37 | 10.5K | £1.7K | +169.3% ▲ |
| Azelaic acid | 37 | 1,260 | £264 | +54.8% ▲ |
| 37 | 1,710 | £3.9K | +80.5% ▲ | |
| Sodium picosulfate | 36 | 6,600 | £595 | -0.8% vs avg |
| Primidone | 36 | 2,044 | £2.3K | +1.2% vs avg |
| Sodium chloride | 36 | 2,672 | £416 | +52.1% ▲ |
| Oxcarbazepine | 35 | 3,658 | £1.2K | +25.2% ▲ |
| 35 | 2,700 | £2.0K | +163.6% ▲ | |
| 35 | 2,310 | £4.2K | +114.4% ▲ | |
| Valsartan | 34 | 1,319 | £254 | -42.3% ▼ |
| Enoxaparin | 34 | 490 | £2.9K | +65.9% ▲ |
| Dipyridamole | 34 | 2,040 | £424 | +32.4% ▲ |
| Bezafibrate | 34 | 964 | £178 | -36.9% ▼ |
| Glycopyrronium bromide | 34 | 1,020 | £887 | -8.8% ▼ |
| Amisulpride | 34 | 2,494 | £368 | -51.6% ▼ |
| Hyoscine hydrobromide | 34 | 2,820 | £459 | -0.4% vs avg |
| Oral rehydration salts | 34 | 5,304 | £2.0K | +17.7% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 34 | 23.2K | £357 | +48.4% ▲ |
| 34 | 657 | £592 | +5.1% ▲ | |
| 34 | 50 | £67 | -84.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.